Autres langues DIAGNOS Inc.

Actions

ADK

CA2524423068

Services et conseils en informatique

Marché Fermé - Toronto S.E. 21:57:09 08/10/2026			Varia. 5j.	Varia. 1 janv.
0,4750 ^CAD	+1,06%		0,00%	+26,67%

28/09	Diagnos Inc. soumet à la Food and Drug Administration américaine une demande d’informations au titre de la section 513(g) concernant le système CARA	CI
28/09	DIAGNOS soumet une demande d’information à la Food and Drug Administration américaine pour son système CARA	MT

Autres langues

06/10	DIAGNOS Provides an Update on Stock Warrants
28/09	Diagnos Inc. Submits Section 513(G) Request for Information to U.S. Food and Drug Administration for Cara System
28/09	DIAGNOS Submits Request for Information to US FDA for CARA System
28/09	DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
14/09	DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
13/08	Diagnos Receives Saudi Fda Medical Device License for Cara System
13/08	Diagnos Receives Saudi Marketing Authorization for CARA System
13/08	Canadian Investment Regulatory Organization Trade Resumption - ADK
13/08	DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
13/08	Canadian Investment Regulatory Organization Trading Halt - ADK
27/07	Diagnos Inc. Receives Health Canada Medical Device Licence for CARA System
27/07	Canadian Investment Regulatory Organization Trade Resumption - ADK
27/07	DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
27/07	Canadian Investment Regulatory Organization Trading Halt - ADK
07/07	Diagnos Announces Warrants Extension
07/07	DIAGNOS to Extend the Exercise Period of Stock Warrants
18/06	DIAGNOS to Issue Shares for To Settle $125,000 of Debt
18/06	DIAGNOS Announces Shares for Debt Settlement
16/06	Diagnos Inc Submits Modified And Updated Health Canada Licence Application For Cara System Platform
16/06	Diagnos Submits Modified And Updated Application to Health Canada For CARA Platform
16/06	DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
12/06	DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
11/06	DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2026
11/06	DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt
05/06	Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform